(NASDAQ: ZSQR) Z Squared's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,464.73%.
Z Squared's earnings in 2026 is -$11,917,015.On average, 3 Wall Street analysts forecast ZSQR's earnings for 2026 to be -$1,079,107, with the lowest ZSQR earnings forecast at -$1,036,789, and the highest ZSQR earnings forecast at -$1,110,845.
In 2027, ZSQR is forecast to generate -$1,142,583 in earnings, with the lowest earnings forecast at -$1,097,776 and the highest earnings forecast at -$1,176,189.